University of Iowa Pharmaceuticals
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 115 S Grand Ave Suite G20 Phar, Iowa City, Iowa (IA) 52242, United States (USA)
- Operations here
- analysislabelmanufacturepackparticle size reductionrelabelrepacksterilize
- FDA identifiers
- FEI 1918751 · DUNS 968854286
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2018-05-04
- NAIDrug Quality Assurance2015-11-10
- NAIDrug Quality Assurance2015-11-06
- NAIDrug Quality Assurance2013-12-13
- VAIDrug Quality Assurance2013-12-13
- VAIDrug Quality Assurance2011-11-11
- NAIDrug Quality Assurance2011-11-09
- VAIDrug Quality Assurance2009-08-27
- NAIDrug Quality Assurance2009-08-21
- VAIDrug Quality Assurance2009-04-21
- NAIDrug Quality Assurance2009-04-03
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- Betaine AnhydrousEton Pharmaceuticals, Inc.
- sodium phenylacetate and sodium benzoateZydus Pharmaceuticals USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.